tiprankstipranks
Trending News
More News >
Helius Medical Technologies (HSDT)
NASDAQ:HSDT
US Market

Helius Medical Technologies (HSDT) Ratios

Compare
395 Followers

Helius Medical Technologies Ratios

HSDT's free cash flow for Q3 2025 was $0.85. For the 2025 fiscal year, HSDT's free cash flow was decreased by $ and operating cash flow was $-506.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
40.03 1.58 3.88 8.40 4.75
Quick Ratio
39.67 1.08 3.64 8.10 4.57
Cash Ratio
39.52 0.50 2.76 7.32 4.15
Solvency Ratio
-0.59 -4.70 -1.63 -1.51 -6.26
Operating Cash Flow Ratio
-4.05 -5.10 -5.54 -7.20 -5.05
Short-Term Operating Cash Flow Coverage
0.00 0.00 -231.47 -265.00 -4.46K
Net Current Asset Value
$ -502.65M$ 941.00K$ 1.96M$ 7.56M$ 9.75M
Leverage Ratios
Debt-to-Assets Ratio
0.00 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.00 0.01 0.02 0.01 <0.01
Debt-to-Capital Ratio
0.00 0.01 0.02 0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
-3.12 3.34 3.27 2.12 1.25
Debt Service Coverage Ratio
-577.43 -811.94 -269.04 -16.33 -5.94K
Interest Coverage Ratio
-24.12 -817.82 0.00 -18.60 0.00
Debt to Market Cap
0.00 0.00 <0.01 <0.01 <0.01
Interest Debt Per Share
0.26 0.01 0.05 1.75 0.03
Net Debt to EBITDA
0.34 0.08 0.42 1.00 0.62
Profitability Margins
Gross Profit Margin
49.63%-11.92%9.47%41.17%42.91%
EBIT Margin
-39223.17%-2665.96%-1905.12%-1875.35%-3473.56%
EBITDA Margin
-39149.63%-2654.42%-1879.97%-1842.95%-3413.79%
Operating Profit Margin
-1635.49%-2673.65%-1929.81%-1971.54%-3475.48%
Pretax Profit Margin
-39358.87%-2258.08%-1374.22%-1788.06%-3473.56%
Net Profit Margin
-39358.87%-2258.08%-1374.22%-1788.06%-3473.56%
Continuous Operations Profit Margin
-39358.87%-2258.08%-1374.22%-1788.06%-3473.56%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
2406.54%84.46%71.21%90.69%99.94%
Return on Assets (ROA)
-77.82%-331.51%-115.05%-81.40%-128.58%
Return on Equity (ROE)
1028.60%-1108.78%-376.60%-172.64%-161.09%
Return on Capital Employed (ROCE)
-3.26%-1008.19%-213.80%-101.42%-158.46%
Return on Invested Capital (ROIC)
-3.26%-999.50%-212.15%-101.06%-158.42%
Return on Tangible Assets
-77.82%-331.51%-115.41%-82.07%-139.41%
Earnings Yield
-7117.98%-0.86%-0.12%-0.23%-0.09%
Efficiency Ratios
Receivables Turnover
0.00 0.82 1.01 2.29 2.08
Payables Turnover
0.19 0.67 1.10 0.74 0.28
Inventory Turnover
0.42 0.53 1.28 0.79 0.63
Fixed Asset Turnover
0.00 4.41 2.80 1.75 1.27
Asset Turnover
<0.01 0.15 0.08 0.05 0.04
Working Capital Turnover Ratio
0.01 0.16 0.06 0.06 0.09
Cash Conversion Cycle
-1.04K 582.44 314.70 129.12 -550.82
Days of Sales Outstanding
0.00 445.72 361.03 159.08 175.51
Days of Inventory Outstanding
868.61 684.22 286.11 464.33 583.02
Days of Payables Outstanding
1.91K 547.50 332.44 494.29 1.31K
Operating Cycle
868.61 1.13K 647.15 623.41 758.53
Cash Flow Ratios
Operating Cash Flow Per Share
-5.16 -4.07 -8.57 -26.51 -136.24
Free Cash Flow Per Share
-5.16 -4.08 -8.59 -26.54 -136.79
CapEx Per Share
0.00 <0.01 0.02 0.03 0.55
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 -2.21K -359.17 -841.76 -247.93
Capital Expenditure Coverage Ratio
0.00 -2.21K -359.17 -841.76 -247.93
Operating Cash Flow Coverage Ratio
0.00 -920.08 -182.74 -130.09 -4.46K
Operating Cash Flow to Sales Ratio
-13.51 -21.23 -16.17 -18.18 -25.65
Free Cash Flow Yield
-14.95%-0.81%-0.14%-0.23%-0.07%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.01 -115.97 -828.38 -441.69 -1.05K
Price-to-Sales (P/S) Ratio
90.36 2.62K 11.38K 7.90K 36.64K
Price-to-Book (P/B) Ratio
-0.03 1.29K 3.12K 762.54 1.70K
Price-to-Free Cash Flow (P/FCF) Ratio
-6.69 -123.27 -701.88 -433.83 -1.42K
Price-to-Operating Cash Flow Ratio
-0.41 -123.33 -703.84 -434.34 -1.43K
Price-to-Earnings Growth (PEG) Ratio
<0.01 2.86 11.49 5.14 28.17
Price-to-Fair Value
-0.03 1.29K 3.12K 762.54 1.70K
Enterprise Value Multiple
0.11 -98.57 -605.11 -427.54 -1.07K
Enterprise Value
-39.02M 1.36B 7.33B 6.20B 19.11B
EV to EBITDA
0.11 -98.57 -605.11 -427.54 -1.07K
EV to Sales
-41.46 2.62K 11.38K 7.88K 36.62K
EV to Free Cash Flow
3.07 -123.17 -701.39 -432.82 -1.42K
EV to Operating Cash Flow
3.07 -123.23 -703.34 -433.33 -1.43K
Tangible Book Value Per Share
-61.80 0.39 1.91 14.84 103.39
Shareholders’ Equity Per Share
-61.80 0.39 1.93 15.10 114.54
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
0.38 0.19 0.53 1.46 5.31
Net Income Per Share
-150.19 -4.33 -7.28 -26.06 -184.51
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.00 0.85 0.72 0.95 1.00
Research & Development to Revenue
3.77 7.04 4.57 5.42 11.48
SG&A to Revenue
1.62 18.21 0.00 0.00 0.00
Stock-Based Compensation to Revenue
2.05 4.85 2.53 0.00 0.00
Income Quality
0.03 0.94 1.18 1.02 0.74
Currency in USD